Skip to main content

Table 2 Relationship between overexpression of Cullin7 and clinico-pathological parameters in HCC

From: Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis

Parameter n Cullin7
negative(%) positive(%) P
Sex
 Male 144 44(30.6) 100(69.4) 0.810
 Female 18 6(33.3) 12(66.7)  
Age(years)
 <50 97 32(33.0) 65(67.0) 0.474
  ≥ 50 65 18(27.7) 47(72.3)  
Tumor size(cm)
 <5 90 29(32.2) 61(67.8) 0.676
  ≥ 5 72 21(29.2) 51(70.8)  
Tumor numbers
 Single 116 34(29.3) 82(70.7) 0.497
 multitude 46 16(34.8) 30(65.2)  
AFP(μg/L)
 <400 98 31(31.6) 67(68.4) 0.793
  ≥ 400 64 19(29.7) 45(70.3)  
HBsAg
 positive 135 41(30.4) 94(69.6) 0.761
 negative 27 9(33.3) 18(66.7)  
Tumor thrombus
 have 69 11(15.9) 58(84.1) 0.000
 no 93 39(41.9) 54(58.1)  
Lymph metastasis
 have 33 5(15.2) 28(84.8) 0.029
 no 129 45(34.9) 84(65.1)  
Pathological grade
 high 37 12(32.4) 25(67.6) 0.780
 moderately 112 33(29.5) 79(70.5)  
 low 13 5(38.5) 8(61.5)  
Hepatic function
 Child A 106 34(32.1) 72(67.9) 0.820
 Child B 36 11(30.6) 25(69.4)  
 Child C 20 5(25.0) 15(75.0)  
Clinical stage
 A 64 30(46.9) 34(53.1) 0.001
 B 11 5(45.5) 6(54.5)  
 C 67 12(17.9) 55(82.1)  
 D 20 3(15.0) 17(85.0)